126 related articles for article (PubMed ID: 4014296)
1. Development of malignant melanoma after levodopa therapy for Parkinson's disease. Report of a case and review of the literature.
Kochar AS
Am J Med; 1985 Jul; 79(1):119-21. PubMed ID: 4014296
[TBL] [Abstract][Full Text] [Related]
2. Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?
Fiala KH; Whetteckey J; Manyam BV
Parkinsonism Relat Disord; 2003 Aug; 9(6):321-7. PubMed ID: 12853231
[TBL] [Abstract][Full Text] [Related]
3. [Levodopa and malignant melanoma--case report and review of the literature. A contribution to causal relationship between levodopa and the development of malignant melanoma].
Kleinhans M; Schmid-Grendelmeier P; Burg G
Hautarzt; 1996 Jun; 47(6):432-7. PubMed ID: 8767657
[TBL] [Abstract][Full Text] [Related]
4. Malignant melanoma and levodopa: is there a relationship? Two new cases and a review of the literature.
Pfützner W; Przybilla B
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 2):332-6. PubMed ID: 9270541
[TBL] [Abstract][Full Text] [Related]
5. Malignant melanoma and levodopa.
Rosin MA; Braun M
Cutis; 1984 Jun; 33(6):572-4. PubMed ID: 6744949
[TBL] [Abstract][Full Text] [Related]
6. Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature.
Zanetti R; Loria D; Rosso S
Melanoma Res; 2006 Jun; 16(3):201-6. PubMed ID: 16718266
[TBL] [Abstract][Full Text] [Related]
7. Levodopa and melanoma: three cases and review of literature.
Rampen FH
J Neurol Neurosurg Psychiatry; 1985 Jun; 48(6):585-8. PubMed ID: 4009196
[TBL] [Abstract][Full Text] [Related]
8. Levodopa administration and multiple primary cutaneous melanomas.
Bernstein JE; Medenica M; Soltani K; Solomon A; Lorincz AL
Arch Dermatol; 1980 Sep; 116(9):1041-44. PubMed ID: 7416757
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease, melanoma, and levodopa.
Fermaglich J; Delaney P
J Neurol; 1977 Jun; 215(3):221-4. PubMed ID: 69691
[No Abstract] [Full Text] [Related]
10. [Melanoma as a possible complication of the treatment of parkinsonism with L-dopa preparations (review of the literature)].
Kande'l EI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(9):126-7. PubMed ID: 2692357
[No Abstract] [Full Text] [Related]
11. Levodopa therapy and malignant melanoma.
Sober AJ; Wick MM
JAMA; 1978 Aug; 240(6):554-5. PubMed ID: 671667
[TBL] [Abstract][Full Text] [Related]
12. Uveal malignant melanoma and levodopa therapy in Parkinson's disease.
Van Rens GH; De Jong PT; Demols EE; Brihaye-Van Geertruyden MF
Ophthalmology; 1982 Dec; 89(12):1464-6. PubMed ID: 7162789
[No Abstract] [Full Text] [Related]
13. [Malignant melanoma and L-dopa. Review of literature on the problem of causal relationship].
Happle
Fortschr Med; 1974 Sep; 92(27):1065-6. PubMed ID: 4457419
[No Abstract] [Full Text] [Related]
14. Levodopa therapy and the risk of malignant melanoma.
Siple JF; Schneider DC; Wanlass WA; Rosenblatt BK
Ann Pharmacother; 2000 Mar; 34(3):382-5. PubMed ID: 10917387
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease, levodopa-use and the risk of melanoma.
Vermeij JD; Winogrodzka A; Trip J; Weber WE
Parkinsonism Relat Disord; 2009 Sep; 15(8):551-3. PubMed ID: 19501540
[TBL] [Abstract][Full Text] [Related]
16. Safety of long-term levodopa therapy in malignant melanoma.
Woofter MJ; Manyam BV
Clin Neuropharmacol; 1994 Aug; 17(4):315-9. PubMed ID: 9316678
[TBL] [Abstract][Full Text] [Related]
17. Levodopa and melanoma.
Lieberman AN; Shupack JL
Neurology; 1974 Apr; 24(4):340-3. PubMed ID: 4856355
[No Abstract] [Full Text] [Related]
18. [Letter: Malignant melanoma during treatment with levodopa].
Pelfréne AF
Nouv Presse Med; 1975 May; 4(18):1365. PubMed ID: 1153302
[No Abstract] [Full Text] [Related]
19. Twenty-two cutaneous primary melanomas in a patient with high genetic predisposition to melanoma receiving levodopa therapy for Parkinson's disease.
Charles J; Templier I; Leroux D; Salameire D; Robert C; Lantuejoul S; Leccia MT
Pigment Cell Melanoma Res; 2009 Dec; 22(6):851-3. PubMed ID: 19708914
[No Abstract] [Full Text] [Related]
20. [Melanoma while using levodopa due to Parkinson's disease--causal association unlikely].
Wobbes T; Bonenkamp JJ
Ned Tijdschr Geneeskd; 2002 Jul; 146(27):1286-8. PubMed ID: 12138675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
